Economic evaluation of donepezil in moderate to severe Alzheimer disease

To investigate the costs to society of Alzheimer disease (AD) care in a multinational, randomized, placebo-controlled trial of donepezil in patients with moderate to severe AD. A total of 290 patients with AD (screening standardized Mini-Mental State Examination score 5 to 17) were randomized to rec...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurology 2004-08, Vol.63 (4), p.644-650
Hauptverfasser:	FELDMAN, H, GAUTHIER, S, HECKER, J, VELLAS, B, HUX, M, XU, Y, SCHWAM, E. M, SHAH, S, MASTEY, V
Format:	Artikel
Sprache:	eng
Schlagworte:	Activities of Daily Living Aged Alzheimer Disease - drug therapy Alzheimer Disease - economics Ambulatory Care - economics Australia Biological and medical sciences Canada Caregivers - economics Cholinesterase Inhibitors - economics Cholinesterase Inhibitors - therapeutic use Cost of Illness Cost-Benefit Analysis Counseling - economics Donepezil Drug Costs Female France Health Resources - economics Health Resources - statistics & numerical data Home Care Services - economics Home Nursing - economics Hospitalization - economics Humans Indans - economics Indans - therapeutic use Institutionalization - economics Male Medical sciences Middle Aged Neurology Nootropic Agents - economics Nootropic Agents - therapeutic use Nursing Homes - economics Piperidines - economics Piperidines - therapeutic use Prospective Studies Surveys and Questionnaires
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!